The QualityStocks Daily Tuesday, May 1st, 2018

Today's Top 3 Investment Newsletters

StockMarketWatch (HTBX) +94.86%

Kiplinger Today (I) +33.37%

BUYINS.NET (INGN) +23.18%

The QualityStocks Daily Stock List

Liquidmetal Technologies, Inc. (LQMT)

Marketbeat, Jason Bond, Promotion Stock Secrets, Penny Pro, Winston Small Cap, Wall Street Mover, Greenbackers, SmallCapVoice, PennyStocks24, Pennybuster, SuperNova Elite, Wealth Daily, PennyStocks Forever, and Penny Stocks VIP reported earlier on Liquidmetal Technologies, Inc. (LQMT), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Liquidmetal® Technologies, Inc. is the leading developer of bulk alloys that use the performance advantages that amorphous alloy technology provides. Amorphous alloys are innovative materials distinguished by their ability to retain a random structure when they solidify. This is versus the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal® Technologies is based in Rancho Santa Margarita, California, where it also has its Manufacturing Center of Excellence.

Liquidmetal has two to three times the strength of titanium and stainless steel. It undergoes processing similar to plastics on the Company's proprietary Liquidmetal molding machines. Liquidmetal Technologies’ class of patented alloys and processes form the underpinning of high performance materials utilized in a wide array of medical, military, consumer, and industrial and sporting goods products.

The Company is the first enterprise to produce amorphous alloys in commercially viable bulk form. This is enabling critical improvements in products across a broad spectrum of industries.

Liquidmetal is processed and solidified in a vitreous or amorphous state (frozen liquid). Liquidmetal® Technologies’ alloys are, in numerous cases, stronger, harder, more elastic, and more wear and corrosion resistant than typically used high-performance alloys.

The Company’s "bulk" amorphous alloys possess advantages usually associated with plastics. These include the ability to undergo molding into precision, complex, and highly finished products. Liquidmetal® Technologies controls the Intellectual Property (IP) rights with over 70 U.S. patents.

Liquidmetal® Technologies and the University of Southern California’s M.C. Gill Composites Center are working together to develop an advanced manufacturing process to produce large-scale amorphous metal and fiber laminate sheets for space applications.

This past August, Liquidmetal® Technologies announced that it elected Mr. Tony Chung as a Director of the Company. As a result, Mr. Chung resigned as Chief Financial Officer (CFO) of Liquidmetal® Technologies. Mr. Bryce Van, former Corporate Controller, was appointed as Vice President of Finance. Mr. Van will serve as the Company’s principal financial and accounting officer.

Mr. Chung served as Liquidmetal Technologies’ CFO for almost a decade. During this time, he served a vital role in ensuring that the Company had sufficient funding for operations. He helped lead Liquidmetal® Technologies to fulfill its vision as the leader of amorphous alloy technology.

Liquidmetal Technologies, Inc. (LQMT), closed Tuesday's trading session at $0.247, up 2.49%, on 584,576 volume with 73 trades. The average volume for the last 60 days is 1,010,530 and the stock's 52-week low/high is $0.1911/$0.44.

chart

Scythian Biosciences Corp. (SCCYF)

OTC Markets, Marketwired, Stockhouse, MarketWatch, Barchart, InvestorIntel, Weed Newswire, Investors Hangout, Stockwatch, YCharts, MicroSmallCap, PotNetwork, Penny Stock Picks, HighRisingStocks, Jet Life Penny Stocks, The Street, and OTC Dynamics reported on Scythian Biosciences Corp. (SCCYF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A research and development company, Scythian Biosciences Corp.’s dedication is to advancing prevention and treatment efforts for concussion and traumatic brain injury with its proprietary cannabinoid-based combination drug therapy. The Company’s mission is to be the first accepted drug regimen for the treatment of concussion. Scythian Biosciences has its corporate headquarters in Toronto, Ontario.

The Company also intends to develop other potential cannabinoid and non-cannabinoid based pharmaceutical products. This includes one that is in development for the treatment of gastro-inflammatory disease.

Regarding its pipeline, Scythian Biosciences’ first patent application covers a two-drug combination therapy for concussive treatment. That is, the combined use of an NMDA antagonist plus a CB2 agonist, either cannabinoid or non-cannabinoid.

Scythian is partnered with the University of Miami and its neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. In addition, the Company has started its global expansion through launching additional cannabis-related activities around the world.

Scythian Biosciences is evaluating a number of strategic initiatives. It is also pursuing partnerships with local cultivators, pharmaceutical import and distribution entities and universities in North America, South America, and the Caribbean and beyond.

In April, Scythian Biosciences announced that Argentina-based ABP S.A. (ABP), a pharmaceutical import and distribution company, which Scythian Biosciences is in the process of acquiring, received its initial purchase order of CBD oil that is to be fulfilled under the supply agreement with Aphria, Inc. a producer of medical cannabis. This order is for Aphria’s well-known CBD oil strain, Rideau.

ABP’s initial order will go to the Dr. Juan P. Garrahan Pediatric Hospital to support a first of its type clinical study centered on treating refractory epilepsy in children. The Dr. Juan P. Garrahan Pediatric Hospital is a highly recognized and one of the most credible medical institutions in South America.

Today, Scythian Biosciences announced that it signed an agreement to extend its earlier announced Letter of Intent (LOI) to acquire MMJ International Investments, Inc. (MMJ), the sole shareholder of ABP S.A. (ABP). ABP is pursuing medical cannabis opportunities in South America.

This agreement extends the deadline for negotiating and entering into a definitive agreement with MMJ from April 30, 2018, to May 11, 2018. The proposed acquisition of MMJ remains subject to approval from the TSX Venture Exchange (TSXV).

Scythian Biosciences Corp. (SCCYF), closed Tuesday's trading session at $3.43, down 6.26%, on 11,110 volume with 25 trades. The average volume for the last 60 days is 4,812 and the stock's 52-week low/high is $3.34/$27.00.

chart

TapImmune, Inc. (TPIV)

Stock Preacher, Beacon Equity Research, SuperStockTips, Penny Stock Craze, Pennybuster, Penny Stocks Finder, InvestorSoup, Penny Pick Finders, Stock News Now, and SeeThruEquityResearch reported previously on TapImmune, Inc. (TPIV), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

TapImmune, Inc. is a leader in the development of novel immunotherapies for cancer, with numerous Phase 2 and Phase 1b/2 clinical studies currently continuing for the treatment of ovarian and breast cancer. The Company’s peptide or nucleic acid-based immunotherapeutics comprise one or multiple naturally processed epitopes (NPEs). The design of these is to comprehensively stimulate a patients' killer T-cells, helper T-cells, and to restore or further augment antigen presentation through utilizing proprietary nucleic acid-based expression systems. TapImmune has its corporate headquarters in Jacksonville, Florida.

TapImmune has developed a unique, cost effective, immunotherapeutic vaccine expression and delivery system. The novel platform is called TapImmune's PolyStart™ technology.

The PolyStart and PAA (Peptide Antigen Array) technologies are straight forwardly and easily managed as a quick, adaptable, plugin-and-play system. This means they can be configured to produce peptides for any desired pathogen.

The Company’s PolyStart™ technology has been strategically designed to directly enhance the immune system's ability to stimulate either or both cytotoxic killer and helper T-cell reactive proprietary peptides, known and expected to be associated with one, or any cancer, infectious disease, or bio-threat. The present focus of TapImmune’s PolyStart technology is on its cancer program (e.g., Her2/neu and folate receptor alpha antigens).

In March, TapImmune announced the publication of clinical data from a Phase 1 trial of TPIV200, its multi-epitope T-cell vaccine targeting Folate Receptor Alpha (FRa) in patients with ovarian and breast cancer. The study by Kalli, Block, et al., titled, "Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients," will be published in the leading peer-reviewed oncology journal Clinical Cancer Research.

The results show that TPIV200 vaccination was well tolerated by all patients. More than 90 percent developed strong and durable antigen-specific immune responses against FRa without regard for HLA type. This aligns with the intended mechanism of action of the vaccine.

TapImmune has started dosing in a 280-patient, grant-funded Phase 2 study of TPIV200 in women with advanced triple-negative breast cancer (TNBC). In addition, the Company has enhanced its Intellectual Property (IP) portfolio for PolyStart™ technology, expanding to cover any polypeptide sequences consisting of poly-antigen arrays (PAAs).

TapImmune’s President and Chief Executive Officer, Mr. Peter Hoang, will participate in a panel discussion and give a company presentation at the 2018 Disruptive Growth & Healthcare Conference, taking place May 8-9, 2018 at Reed Smith LLP in New York, New York.

TapImmune, Inc. (TPIV), closed Tuesday's trading session at $2.99, up 12.83%, on 66,069 volume with 265 trades. The average volume for the last 60 days is 41,779 and the stock's 52-week low/high is $2.58/$4.41. 

chart

Uniroyal Global Engineered Products, Inc. (UNIR)

Zacks, MarketWatch, and Marketbeat reported on Uniroyal Global Engineered Products, Inc. (UNIR), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Uniroyal Global Engineered Products, Inc., by way of its subsidiaries, is a foremost manufacturer of vinyl coated fabrics. These fabrics are durable, stain resistant, cost-effective alternatives to leather, cloth, and other synthetic fabric coverings. Formed in 1992, Uniroyal Global Engineered Products (UNIR) is based in Sarasota, Florida. The Company’s shares trade on the OTCQB.

UNIR is a top supplier of vinyl coated fabric materials for the automotive and commercial industries. The Company’s products in the automotive industry are used largely in seating, door panels, head and arm rests, security shades, and trim components.

UNIR’s non-automotive applications include outdoor seating for utility and sports vehicles, and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pool liners, pram and nursery, movie screen, and decorative surface applications.   

The Company’s chief brand names include Naugahyde®, BeautyGard®, Flameblocker™, and Spirit Millennium®. In addition, they include Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.

The Company’s 2016 revenue was derived 65 percent from the automotive industry and about 35 percent from the recreational, industrial, indoor and outdoor furnishings, hospitality, and health care markets.

In 2016, UNIR’s Naugahyde brand introduced Casablanca. This is a linen-textured vinyl-coated fabric. Casablanca combines the look and feel of linen with the performance of Naugahyde®.

All of Casablanca’s patterns are flame retardant, stain resistant, as well as anti-microbial. Casablanca features Naugahyde’s exclusive Advanced BeautyGard® top coat finish. This collection was developed with hospitality, contract, marine, and healthcare markets in mind.

In November, Uniroyal Global Engineered Products reported its financial results for Q3 ended October 1, 2017.

Mr. Howard R. Curd, Chairman and Chief Executive Officer of UNIR, said, “Overall, this was a very tough quarter from a sales perspective. The reported decline in Net Sales is isolated to our North American operations as we continue to see gains in our European operations.  The North American operations struggled with sharply lower volume, particularly in the automotive sector as volume expectations from certain platforms were not achieved. US consumer preferences are switching to light trucks, SUVs and crossovers which are not significant drivers of our revenue. As a result, many of the US automotive manufacturers idled production lines or entire assembly plants for multiple weeks to reduce inventories. We have taken corrective action to “right size” the costs associated with the lower volumes as well as eliminate certain administrative expenses.”

The Company reported net sales of $22,498,456 and a net loss available to common shareholders of $477,553 or a loss of $0.03 per diluted share for Q3.

Uniroyal Global Engineered Products, Inc. (UNIR), closed Tuesday's trading session at $1.665, up 0.91%, on 550 volume with 4 trades. The average volume for the last 60 days is 3,703 and the stock's 52-week low/high is $1.00/$3.45.

chart

Geospatial Corp. (GSPH)

HotStockChat, SmallCapVoice, Penny Sleuth, and The Street reported earlier on Geospatial Corp. (GSPH), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Geospatial Corp. is a leading innovator of asset management/analytics/mapping software and 3D mapping technologies. The Company utilizes integrated technologies to determine the accurate location and position of underground pipelines, conduits, and other underground infrastructure data. This allows it to create accurate three-dimensional (3D) digital maps and models of underground infrastructure. Geospatial is based in Sarver, Pennsylvania. The Company’s shares trade on the OTC Markets’ OTCQB.

Geospatial provides integrated data acquisition technologies. These technologies accurately locate and map underground and aboveground infrastructure assets, including pipelines and surface features by way of its GeoUnderground Cloud-Based Portal. The design of GeoUnderground is around the Google Maps API. GeoUnderground is Geospatial’s cloud-based Geographic Information System (GIS) platform. It provides clients with a complete solution to their underground and aboveground asset management needs.

The Company has new Quality Assurance (QA) and Installed Locational Integrity Management (ILIM) programs for underground pipelines. It provides comprehensive QA programs and ILIM programs for underground pipelines and conduits installed via Horizontal Directional Drilling (HDD) methods irrespective of depth, material, or soil conditions. The service addresses the need for accurate 3D mapping of critical pipeline segments, which exceeds regulatory requirements and supports integrity and reliability demands.

Geospatial utilizes a collection of data acquisition tools and the Company cost-effectively maps most pipelines to an accuracy of less than 10 cm (3.9 inches). Its technologies map HDPE – PVC or metallic underground pipes and conduits from 1-inch diameter and greater to depths of 50 feet (15 m). Geospatial manages the critical infrastructure data on GeoUnderground.

GeoUnderground is a robust Cloud-Based GIS database. This database allows users to view and use this 3D pipeline mapping information securely from any desktop or mobile device.

This past August, Geospatial announced that it completed the mapping of three pipelines under the Savannah River for an industrial facility in Savannah, Georgia. The project concluded in late August. This project had a value of roughly $125,000 in revenue to the Company.

The client is an international industrial corporation. It selected Geospatial along with Jacobs Engineering from a number of companies to perform the technical task of mapping one effluent waste pipeline and two bundled high-voltage conduits. These all run underneath the Savannah River.

Geospatial has been approved as a vendor for IGAPP, which is run by Engility Holdings, Inc. in support of the National Geospatial-Intelligence Agency's (NGA's) mission. NGA is a combat support agency under the U.S. Department of Defense and an intelligence agency of the United States Intelligence Community. Its main mission is collecting, analyzing, and distributing geospatial intelligence in support of national security.

Recently, Geospatial announced the addition of Mr. Rob Brook, an internationally recognized infrastructure and utility industry veteran, to the Company's executive management team. Mr. Brook, who will serve as Team Lead GeoUnderground, Geospatial’s proprietary cloud-based GIS software, is a former Senior Director – Gas Infrastructure for Pacific Gas & Electric (PG&E).

In addition, Mr. Brook served as the Global Pipeline and Gas Utilities Industry Manager for ESRI, the GIS software industry leader. Moreover, he has served on the Board of the Pipeline Open Data Standard (PODS). Mr. Brook has developed a strong understanding of enterprise IT (Information Technology), asset management, public works, pipelines, and gas utilities integrity management solutions.

Geospatial Corp. (GSPH), closed Tuesday's trading session at $0.025, up 6.38%, on 104,650 volume with 5 trades. The average volume for the last 60 days is 85,233 and the stock's 52-week low/high is $0.017/$0.055.

chart

Namaste Technologies, Inc. (NXTTF)

Stockhouse, OTC Markets, MarketWatch, InvestorsHub, InvestorsHangout, TradingView, and Daily Marijuana Observer reported on Namaste Technologies, Inc. (NXTTF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Namaste Technologies, Inc. is the largest online retailer for medical cannabis delivery systems around the world. The Company distributes vaporizers and smoking accessories via e-commerce sites in 26 countries and with 5 distribution hubs located internationally. Namaste’s long term strategy is to become a foremost supplier of legal cannabis products as the cannabis market is legalized in each nation. Namaste Technologies has its corporate office in Toronto, Ontario. Its U.S. office is in Jupiter, Florida and its Bahamas office is in Lyford Cay.

The Company owns and operates online retail sites with a presence in numerous countries. Namaste Technologies is a worldwide leader in delivery systems for dry herbs that can include medicinal cannabis where legally available. Through vaporizer sales and the selling of glass and pipes and other dry herb related paraphilia, Namaste has a very strong channel to sell to end consumes once it is legalized globally.

In addition, Namaste is active in product development and manufacturing. It will launch the Grizzly Eclipse Vaporizer soon.  The Company is in the final stages of its Cannmart license to gain approval to distribute cannabis in Canada. Legalization is in the final stages in Canada.

Last month, Namaste Technologies announced that it signed a stock purchase agreement with ESC Hughes Holdings Limited to sell the Company’s wholly-owned U.S. subsidiary, Dollinger Enterprises US, Inc. This Agreement includes the sale of the domain names Everyonedoesit.com and NamasteVapes.com that combined represent less than 7 percent of Namaste Technologies’ current gross revenue.

This week, Namaste Technologies announced that it signed a non-binding Letter of Intent (LOI) with O Cannabis We Stand On Guard For Thee. O Cannabis will provide patient consultation services to Namaste’s wholly-owned subsidiary, NamasteMD, Inc.

With this LOI, O Cannabis will provide management services to NamasteMD. This will include patient consultations, education, strain recommendations and medical document issuance to qualified patients under the guidance of nurse practitioners.

Furthermore, O Cannabis will offer a select range of Namaste Technologies’ vaporizer hardware in its online platform. O Cannabis offers affordable medical cannabis telemedicine appointments to patients throughout Canada.

Yesterday, Namaste Technologies announced record breaking sales for the month of November 2017, as reported by Namaste (including shipping revenues after discounts and refunds) of C$2.2M, equating to a 69 percent month-on-month increase and a 146 percent year-on year increase. This represents the Company’s highest month of revenue in its history.

Namaste has acquired the above-mentioned Cannmart, Inc. This is a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program). Via Cannmart, Namaste Technologies is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market.

Namaste Technologies has majority market share in Europe and Australia. The Company has operations in the United Kingdom, the United States, Canada and Germany. Moreover, it has opened new supply channels into developing markets. This includes Brazil, Mexico, and Chile.

Namaste Technologies, Inc. (NXTTF), closed Tuesday's trading session at $1.23, down 1.60%, on 496,793 volume with 329 trades. The average volume for the last 60 days is 394,868 and the stock's 52-week low/high is $0.1319/$3.4715.

chart

ImageWare Systems, Inc. (IWSY)

Greenbackers, Microcapmillionaires, Pennybuster, PennyStocks24, Wall Street Daily, Wall Street Resources, and TaglichBrothers reported on ImageWare Systems, Inc. (IWSY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ImageWare Systems, Inc. is a top developer of mobile and cloud-based multi-modal biometric identity management solutions, providing biometric, secure credential, and law enforcement technologies. The Company’s biometric product line is scalable for global deployment. ImageWare Systems is based in San Diego, California. The Company also has offices in Portland, Oregon; Ottawa, Ontario; and Mexico City, Mexico.

ImageWare Systems’ biometric product line includes a multi-biometric engine. This engine is hardware and algorithm independent. This allows the enrolment and management of unlimited population sizes.

The Company has its GoCloudID.com. GoCloudID.com is a highly modular, SOA-based software platform. It delivers a premier capability to quickly develop and deploy highly secure, yet flexible standards based identity solutions.

ImageWare Systems’ next-generation cloud identity management and authentication service is GoMobile Interactive™ (GMI). GMI is a cloud-based, multi-modal biometric mobile identity management solution. GMI is built upon the award-winning IWS Biometric Engine® (IWS BE), an SOA based server platform, which enables advanced biometric data process and management with ESB connectivity.

The Company also has its EPI Builder®. This provides the foundation for a multi-modal biometric capture platform that ensures device interoperability and support for centralized and distributed deployment models. Products also include IWS Biometric Engine®. This is the first and only truly multi-modal, device-and algorithm-independent biometric software platform.

Additionally, ImageWare has its GoVerifyID solution. GoVerifyID is its patented mobile biometric user authentication solution. GoVerifyID technology provides turnkey solutions to secure enterprise systems from security infrastructure providers such as Fujitsu, Microsoft, IBM, CA, HPE and other vendors.

Furthermore, ImageWare has its GoVerifyID® Enterprise Suite. This is a unique, multi-modal, multi-factor biometric authentication solution for the enterprise market. GoVerifyID Enterprise Suite is an algorithm-agnostic solution.

ImageWare delivers innovative mobile capabilities to the wireless, financial services, as well as healthcare sectors. The pillphone® enabled by the Company’s GoMobile interactive push application platform, is Food and Drug Administration (FDA) cleared. It is the only mobile health management application secured by biometrics.

In April, ImageWare Systems provided its first sales update for 2018. Mr. Jim Miller, Chairman and Chief Executive Officer of ImageWare Systems, said that “We have sold additional licenses to an existing customer who is expanding the use of the IWS Biometric Engine and three of our partners have made initial sales of GoVerify ID® (GVID). We continue to expect that many initial sales will often be made for enterprise/employee users and then adding users as services are rolled out to their customers.”

ImageWare Systems announced last week that on May 10, 2018 it will file its Form 10-Q soon after the close of the stock market and will host an investor update conference call the same day at 1:30pm PT (4:30pm ET) to review Q1 results. Management’s discussion will include ImageWare Systems’ direct sales efforts and partner sales efforts.

ImageWare Systems, Inc. (IWSY), closed Tuesday's trading session at $1.55, down 1.27%, on 51,959 volume with 33 trades. The average volume for the last 60 days is 109,106 and the stock's 52-week low/high is $0.8117/$2.24.

chart

Biostage, Inc. (BSTG)

Investors Hub, Stock News Gazette, StockNewsJournal, Simply Wall St, BusinessInsider, Barchart, The Street, StockTwits, Zacks, InvestorPoint, and AllStockNews reported on Biostage, Inc. (BSTG), and today we report on the Company, here at the QualityStocks Daily Newsletter

Biostage, Inc. is a biotechnology company based in Holliston, Massachusetts. It is developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea. The Company formerly went by the name Harvard Apparatus Regenerative Technology, Inc. It changed its corporate name to Biostage, Inc. in March 2016. Established in 2007, Biostage lists on the OTC Markets Group’s OTCQB.

Biostage is developing bioengineered organ implants based on its Cellframe™ technology. This technology combines a proprietary biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants.

Cellspan implants are undergoing development to treat life-threatening conditions of the esophagus, bronchus or trachea with the hope of considerably improving the treatment paradigm for patients. Biostage, based on its preclinical data, has selected life-threatening conditions of the esophagus as the initial clinical application of its technology.

Biostage’s novel Cellframe™ technology is engineered to stimulate the body’s signaling pathways and natural healing process to regenerate and restore organ function. The Company’s Cellframe technology is based on more than 20 years of scientific progress in the fields of tissue engineering, cell biology, and material science. Cellframe technology combines the best attributes of a synthetic scaffold with tissue engineering and cell biology.

The Cellspan implant is delivered directly to the site where tissue regeneration is required. It is intended to play a pivotal role in the success of in situ tissue regeneration through providing stem cell-derived biological signals, and three-dimensional guidance and support, for cell growth and regeneration.

Moreover, Biostage’s plan is to establish a presence in China to address the largest incidence of esophageal cancer worldwide. The Company has built a dedicated internal team of materials scientists, engineers and biologists. They are working with Biostage’s external collaborators to bring Biostage products to the patients who need them as fast as possible.

This past March, Biostage announced it was awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the Eunice Kennedy National Institute of Child Health and Human Development (NICHD). The NICHD is part of the National Institute of Health. NICHD awarded Biostage the grant as part of its mission to "ensure that every person is born healthy and wanted, and that all children have the chance to achieve their full potential for healthy and productive lives."

The grant funding will support Biostage's development and preclinical testing of its Cellspan™ Esophageal Implant (CEI) for treatment of pediatric esophageal atresia. The Company’s Sumati Sundaram, PhD and Christine Finck, MD, FACS, Surgeon-In-Chief at Connecticut Children's Medical Center are the main investigators on this grant.

Recent highlights for Biostage include announcing the first successful in-human use of a Cellspan™ implant to regenerate a patient's esophagus. Furthermore, the Company published successful results of a pre-clinical study demonstrating esophageal regeneration in large animals.

Biostage, Inc. (BSTG), closed Tuesday's trading session at $2.60, down 3.70%, on 417 volume with 5 trades. The average volume for the last 60 days is 5,500 and the stock's 52-week low/high is $0.60/$13.00.

chart

MGX Minerals, Inc. (MGXMF)

InvestorsHub, Stockhouse, Capital Equity Review, The Street, Stockwatch, The StreetWise Reports, MarketWatch, OTC Markets, Morningstar, 4-Traders, and Barchart reported on MGX Minerals, Inc. (MGXMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MGX Minerals, Inc. is a diversified resource company based in Vancouver, British Columbia. The Company centers on the development of large-scale industrial mineral portfolios in specific commodities and jurisdictions that will fuel the new energy economy. MGX Minerals controls significant interest in lithium, magnesium and silicon assets throughout North America. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Regarding size and scale, MGX Minerals has regional control in the majority of industrial mineral projects in the jurisdictions it operates. Moreover, concerning near-term potential, MGX concentrates on assets that offer streamlined development timelines and low initial capital expenditures (Capex).

MGX Minerals’ business strategy is to identify commodities as well as jurisdictions where large-scale development opportunities exist. Its strategy is to also build its asset portfolio through aggressive acquisition to quickly build and enhance long-term portfolio value. Furthermore, its strategy is to engage industry experts to lessen execution risk and speedily increase time to market.

The Company has developed a proprietary, low-energy design process (Rapid Recovery Process) that is patent-pending. The design of it is specifically for highly-mineralized brine associated with oilfields. The process quickly concentrates lithium and other minerals in brine.

Regarding independent confirmation of the Rapid Recovery Process, testing was carried out by a third-party laboratory (Saskatchewan Research Council (SRC)). SRC successfully recovered 83.7 percent of lithium from a representative sample of brine. Lithium was concentrated to 461 ppm from the representative sample containing 71 ppm.

MGX Minerals announced that its 100 percent wholly-owned subsidiary ZincNyx Energy Solutions entered into a Partnership Agreement with Digital Energy Corporation to deploy Zinc-Air Fuel Cell Technology in New York City. With this agreement, Digital Energy will install the ZincNyx battery system at a demonstration site in New York City.

Upon successful completion of the initial project, ZincNyx and Digital Energy will develop more installation sites. They will also work to expand distribution of the ZincNyx technology. Digital Energy is a project development and energy consulting firm.

ZincNyx works to meet the increasing need for secure and reliable power. MGX Minerals’ intention is to publicly list ZincNyx and pay a partial share dividend to MGX shareholders of record.

Last week, MGX Minerals provided an update on its Paradox Basin Petrolithium Project. The Project includes the 80,380-acre Blueberry Unit, a recently unitized Federal Oil and Gas Unit created as part of the Project. The 110,000 acre Paradox Project represents the first large-scale integrated petroleum and lithium exploration project in the U.S. It is situated proximate to the Lisbon Valley oilfield within the Paradox Basin.

After approximately two months of fieldwork, crews have completed Paleontology Surveying. They are nearing completion of the Archeological Survey. So far, all locations have been surveyed out with 163 new sites located along with 12 sites that need re-documenting.

Documentation recording for the survey started last week and will take about one week to complete. Pending Bureau of Land Management (BLM) approval, a Seismic Survey at the Paradox Project is scheduled to begin in early August.

In North America, MGX Minerals reports the completion of brine analysis and pilot plant processing of samples originating from an industrial wastewater stream and geothermal lithium brine samples. Its investment bank Capstone Headwaters LLC is assisting in negotiations.

In South America, MGX Minerals has completed pilot plant testing on brine samples originating from manifold salars situated in Chile. The Company has entered into a joint brine testing agreement with several South American mining companies. The parties are now working to identify potential joint-venture (JV) locations, which will utilize MGX’s lithium extraction technology.

MGX Minerals, Inc. (MGXMF), closed Tuesday's trading session at $0.68, down 2.17%, on 588,592 volume with 142 trades. The average volume for the last 60 days is 300,083 and the stock's 52-week low/high is $0.543/$1.5835.

chart

Regen BioPharma, Inc. (RGBP)

InvestorTrendz, TopPennyStockMovers, ProTrader, SmallCapVoice, Wall Street Mover, and TheMicrocapNews reported previously on Regen BioPharma, Inc. (RGBP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Regen BioPharma, Inc. is a biotechnology company headquartered in La Mesa, California. It works to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company’s objective is to speedily advance these technologies through pre-clinical and Phase I/II clinical trials. Checkpoint Immunology, Inc. is a wholly-owned subsidiary of the Company.

Regen BioPharma is presently concentrating on checkpoint inhibitor and gene silencing therapies for treating cancer. Additionally, the Company is focusing on developing stem cell treatments for aplastic anemia.

In essence, Regen BioPharma is working to increase the quality of life via therapies involving small molecules, stem cell treatments, and the body's own immune system. Currently, it is developing products treating blood disorders using small molecules and gene silencing (DiffronC), and treating cancer with immunotherapy (dCellVax).

Furthermore, Regen BioPharma is modulating important molecular processes in cancer stem cells through its patented molecular targeting approaches (BORIS). Moreover, the Company is repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate).

Regen BioPharma is concentrating on small molecules to activate and inhibit its chief target of interest, NR2F6. The Company is continuing to develop the NR2F6 program in-house before entering into any potential partnerships.

Regen BioPharma has granted CheckPoint Immunology an exclusive global license to develop and commercialize Regen's NR2F6 technology for human therapeutic use. The goal of the license grant is the separation of Regen BioPharma’s small molecule technology from its other Intellectual Property (IP) to facilitate any future transactions involving small molecule therapies centered on the NR2F6 checkpoint.

Regen BioPharma announced in December of 2017 filing a patent application covering composition of matter and methods of use related to molecules identified in its small molecule program that activate and inhibit NR2F6 (Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans).

This past February, Regen BioPharma announced that it moved into the second stage of its earlier-announced program to ascertain the three-dimensional structure of NR2F6 - with and without its proprietary small molecule drugs bound to it. The object of this structure-determination program is to highlight how the small molecules bind to and modulate NR2F6 activity. The NR2F6 nuclear receptor has been identified as a potentially very vital immune cell inhibitor (an immune checkpoint) and cancer stem cell differentiator.

Regen BioPharma has been methodically optimizing small molecules, which bind to, and activate, the NR2F6 nuclear receptor. The process is close to completion. The main and back up compounds are being readied for final pre-clinical mouse experiments.

Mr. David Koos, Ph.D., Chairman & Chief Executive Officer of Regen BioPharma, said, "Having an optimized lead candidate is the culmination of a great deal of strategic planning and scientific work. I am gratified that we are so close to achieving this important milestone and look forward to the next phase of drug development."

Regen BioPharma, Inc. (RGBP), closed Tuesday's trading session at $0.0274, up 11.84%, on 22,102 volume with 5 trades. The average volume for the last 60 days is 161,631 and the stock's 52-week low/high is $0.018/$0.1277.

chart

Liberated Syndication, Inc. (LSYN)

Promotion Stock Secrets, InvestorsHub, and Stockhouse reported on Liberated Syndication, Inc. (LSYN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Liberated Syndication, Inc. engages in the podcast hosting services business in the United States. The Company formerly went by the name Webmayhem, Inc. It changed its name to Liberated Syndication, Inc. in August 2016. The Company is headquartered in Pittsburgh, Pennsylvania. Liberated Syndication lists on the OTC Markets Group’s OTCQB.

Concerning Liberated Syndication’s OnPublish – Multiple Destination Publishing, its services provide independent podcasters tools to create a premier podcast and get that podcast into as many platforms as possible. The Company is the largest leading podcast network. It provides podcast hosting services for producers of podcasting content; independent podcasters’ tools to publish content; as well as mobile apps for podcasts.

In addition, the Company offers advertisement insertion on certain of the producers’ content. Regarding Podcast Hosting Services, hosting is optimized for audio and video podcast distribution. The network is quick and reliable. Moreover, unmetered bandwidth and flexible storage space increases over time.

Pertaining to MyLibsyn – Premium Content, it is a comprehensive subscription management service. The MyLibsyn offering includes a custom premium page and mobile apps available across four markets. One’s subscribers sign up and create one username and password. They can access their subscription across all available apps and one’s branded premium page.

Furthermore, Liberated Syndication has its LibsynPRO – Enterprise Solutions. This is for professional media producers and corporate customers. LibsynPRO features podcast network tools. It is a turn-key podcast network solution. It allows for as many different shows and episodes as required. Also, effective reports communicate sophisticated data on network, show, episode, device, and geographic performance.

Regarding Mobile Apps for Podcast, the Libsyn custom smartphone app for podcasters involves audiences beyond one’s regular audio or video episodes. Four different types of content are accepted by the app (audio, video, PDF and text). All in one place, a user can offer their audience extras, blog posts, transcripts, and more.

The Liberated Syndication publishing platform integrates content delivery to social media and blog platforms via OnPublish, the Company’s Facebook App and HTML5 player. OnPublish incorporates publishing to Facebook, Twitter, WordPress and Blogger right from Liberated Syndication (Libsyn).

Liberated Syndication has acquired Internet hosting company Pair Networks, Inc. (Pittsburg, Pennsylvania). Pair Networks provides a complete range of quick, powerful and reliable Web hosting services. Pair offers a set of Internet services from shared hosting to virtual private servers to customized solutions.

In April, Liberated Syndication announced a 69 percent increase in LibsynPro signups in the first three months of 2018, over the same period last year.

Mr. Rob Walch, VP of Podcaster Relations, said, "The breadth and number of new customers for LibsynPro over the last few quarters has been amazing, ranging from U.S. governmental agencies, large corporations and big media brands. LibsynPro delivers industry best uptime, podcast statistics and advertising stitching tools.”

In 2017, Liberated Syndication delivered greater than 7.2 Billion downloads. The Company hosts more than 3.96 Million media files for over 44,000 podcasts, including usually approximately 35 percent of the top 200 podcasts in iTunes.

Liberated Syndication, Inc. (LSYN), closed Tuesday's trading session at $1.65, up 3.12%, on 1,750 volume with 3 trades. The average volume for the last 60 days is 24,125 and the stock's 52-week low/high is $0.72/$1.90.

chart

The QualityStocks Company Corner

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

GLOBAL HEMP GROUP INC. (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) is pleased to announce that the Company, in partnership with Marijuana Company of America, Inc. (OTC:MCOA) has acquired a 109 acre agricultural property in Scio, Oregon (the “Property”) for the cultivation of high CBD yielding hemp for the upcoming 2018 growing season.

Marijuana Company of America Inc. (MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.03015, up 5.24%, on 5,857,884 volume with 289 trades. The average volume for the last 60 days is 5,446,518 and the stock's 52-week low/high is $0.0181/$0.0728.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (POS), e-commerce and mobile devices, today announces that its PayOnline subsidiary is partnering with Bank Sputnik to offer a comprehensive multi-channel payment facilitator solution for SMB merchants in the Russian Federation. Also today, NetworkNewsWire issued a report on the company detailing how it’s no surprise that payment processors like Net Element are doing so well, given that  total payment revenues worldwide climbed to $1.6 trillion in 2016, and the market is projected to reach $2.2 trillion by 2021.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $8.40, up 5.93%, on 580,904 volume with 2,619 trades. The average volume for the last 60 days is 971,247 and the stock's 52-week low/high is $2.556/$33.51.

Recent News

chart

Hiku Brands Co. Ltd. (DJACF)

The QualityStocks Daily Newsletter would like to spotlight Hiku Brands Co. Ltd. (DJACF).

Hiku Brands Company Ltd. (CSE: HIKU) ("Hiku" or the "Company") was pleased to announce today the filing of its financial statements and management discussion and analysis for the fiscal year ending December 31, 2017.

Headquartered in British Columbia’s picturesque Okanagan Valley, Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) iis a premium cannabis lifestyle brand growing high-quality handcrafted cannabis flower. Hiku’s wholly owned subsidiary is a licensed producer of cannabis under the ACMPR that has requested its Pre-Sales License Inspection, the last step prior to receiving a license to sell cannabis under the ACMPR. Hiku’s Dominion Facility is a state-of-the-art ACMPR licensed production facility capable of producing approximately 660 kg year of dried cannabis flower. Hiku’s second facility, a 22,580 sq ft warehouse, “the FUTURE LAB”, is targeting its Phase 1 completion by Q2 2018 and once the facility is fully built-out utilizing an industry leading multi-tier system powered by LED lighting provided by Fluence BioEngineering, Hiku’s annual production capacity is expected to be in excess of 5,000 kgs. Hiku was founded by the proven entrepreneurial team that started SAXX Underwear®.

On December 21, 2017, Hiku and TS Brandco Holdings Inc. (“Tokyo Smoke”) announced that they have entered into a binding Letter of Intent (“LOI”) to merger the two companies and create a uniquely positioned cannabis company combining a best-in-class craft cannabis producer with an award-winning lifestyle brand and retail-focused cannabis company. It is anticipated that the combined company resulting from the merger will use the name “Hiku Brands Company Ltd.” (“Hiku”) to refer to the brand house containing premium cannabis brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku recently closed on a $10 million strategic equity investment from Aphria Inc. (“Aphria”) (TSX:APH and US OTC: APHQF) to expand their product offering ahead of the recreational market.

Upon completion of the merger, Hiku will have a robust cash position of approximately $31 million, which it plans to invest in expanding its cannabis production capacity, growing its retail footprint, and adding select brands to its portfolio through highly strategic and complementary acquisitions.

About Tokyo Smoke
Founded in 2015 by Alan and Lorne Gertner, Tokyo Smoke is an award-winning cannabis lifestyle brand that brings sophistication and design to the fast-growing industry. With immersive experiences and design-first, non-dispensary retail spaces selling coffee, cannabis accessories and design products, the brand has six locations in Canada, with plans to expand nationwide. Recently named “Brand of the Year” at the Canadian Cannabis Awards, Tokyo Smoke has showcased excellence in brand storytelling, and has developed an international reputation as the go-to destination for engaging content offerings within the industry. With the acquisition of fellow designer cannabis brand Van der Pop, and by partnering with Aphria Inc. (TSX: APH and US OTC: APHQF) and WeedMD (TSXV: WMD), Tokyo Smoke continues to be the leading Canadian brand in the cannabis space.

About Hiku
Hiku is focused on handcrafted cannabis production, immersive retail experiences, and building a portfolio of iconic, engaging cannabis lifestyle brands. Hiku is differentiated as the only Canadian craft cannabis producer with a significant national retail footprint and a growing brand house including premium cannabis lifestyle brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku’s wholly owned subsidiary, DOJA Cannabis Ltd., is a federally licensed producer pursuant to the ACMPR, owning two production facilities in the heart of British Columbia’s Okanagan Valley. The company operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario.

Hiku Brands Co. Ltd. (DJACF), closed the day's trading session at $1.17, up 5.93%, on 133,948 volume with 140 trades. The average volume for the last 60 days is 124,815 and the stock's 52-week low/high is $0.20/$3.8799.

Recent News

chart

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) is working to build the largest global pure-play cobalt exploration and development company, with its North American portfolio of assets that are highly leveraged to the rapidly growing cobalt market being pushed by rising interest in electric vehicles. Established in early 2017, First Cobalt’s primary emphasis is on its Greater Cobalt Project located about 500 km north of Toronto, Ontario.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.601, up 0.84%, on 67,925 volume with 49 trades. The average volume for the last 60 days is 153,322 and the stock's 52-week low/high is $0.3148/$1.3041.

Recent News

chart

Uneeqo Inc. (OTC: UNEQ)

The QualityStocks Daily Newsletter would like to spotlight Uneeqo Inc. (UNEQ).

Uneeqo Inc. (OTC: UNEQ) is a Nevada corporation that recently incorporated and registered a new subsidiary, Serpentcoin Limited (“SCL”), in the United Kingdom. Through this subsidiary, Uneeqo has a new focus – a peer-to-peer digital token called “SerpentCoin” built upon a distributed, decentralized public ledger that is viewable and easily audited by transacting parties through unbreakable, encrypted smart contracts.

Uneeqo Inc. (OTC: UNEQ) is a Nevada corporation that recently incorporated and registered a new subsidiary, Serpentcoin Limited (“SCL”), in the United Kingdom. Through this subsidiary, Uneeqo has a new focus – a peer-to-peer digital token called “SerpentCoin” built upon a distributed, decentralized public ledger that is viewable and easily audited by transacting parties through unbreakable, encrypted smart contracts.

SerpentCoin is built upon Cardano, a technologically superior blockchain platform developed from a scientific philosophy by a global team of leading academics and engineers. SerpentCoin’s design platform includes several mission critical elements that directly support this forward-thinking technology that is constantly evolving in a fast-moving space.

Projects under development include:

  • Medusa – Each cryptocurrency requires a “wallet,” which is essentially a software application that can be installed on any computer or smartphone, to store tokens. SerpentCoin’s highly-engineered Medusa wallet will contain refined security features developed specifically for Cardano blockchain technology and protects assets with the most advanced cryptography. Medusa will not only support SerpentCoin tokens, but many others as well.
  • Temple – Think of this as a “treasury” which underpins the long-term core value of SerpentCoin. On every transaction through the SerpentCoin platform, 1.5 percent will be deposited in the platform’s Temple. Each quarter, Guardians (or holders of SerpentCoin) will have the chance to vote on how these treasury funds are invested into identified healthcare projects and technologies that benefit humanity.
  • Entwine – This refers to unbreakable smart contracts that allow SerpentCoin Guardians to make agreements on virtually anything while being assured the other party will meet its obligation. Through the use of double-deposit, theft is impossible, no escrow is needed, and no “middlemen” or websites are involved that could hold onto funds.

At the helm of the Uneeqo and SerpentCoin Limited team is Dr. Abel N J Haque, a business development professional with extensive experience in international business in the medical, technology and automotive sectors, as well as a leading consultant in regenerative medicine and cell therapy. Dr. Haque currently serves as an orthopaedic surgery technical consultant for Synergy Medical Technologies where he provides autologous stem cell cartilage transplants under contract to the Royal National Orthopaedic Hospital, University College, Long. In the past, Dr. Haque has held various positions at Wright Medical Europe and Stryker Corporation, along with many of its mergers and acquisitions.

Uneeqo Inc. (UNEQ), closed the day's trading session at $0.085, even for the day, on 114,300 volume with 23 trades. The average volume for the last 60 days is 21,503 and the stock's 52-week low/high is $0.0075/$0.085.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Lexaria Bioscience Corp's. (CSE:LXX) (LXX.CN) (CNSX:LXX) (OTCQX:LXRP) recently announced definitive technology licensing agreement with GP Holdings LLC, a developer of cannabis infused beverages, providing access to its breakthrough technology that enhances bioavailability. Also today, CannabisNewsWire released a report on the company detailing how LXRP recently announced a new licensing agreement with Nuka Enterprises LLC to renew Nuka’s DehydraTECH™ license rights for use in its 1906 brand of cannabis chocolates. To view the full press release, visit: http://cnw.fm/5rxR6.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.59, up 1.27%, on 159,166 volume with 216 trades. The average volume for the last 60 days is 217,650 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

chart

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF)

The QualityStocks Daily Newsletter would like to spotlight Global Hemp Group, Inc. (GBHPF).

British Columbia-based hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) this morning announced that the company, together with its partner Marijuana Company of America (OTC: MCOA), has acquired a 109-acre agricultural property for the cultivation of high CBD yielding hemp for the approaching 2018 growing season. To view the full press release, visit: http://cnw.fm/HgGS7.

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTCQB: GBHPF), headquartered in British Columbia, Canada, is a publicly traded company founded in 2014. Global Hemp Group is focused on acquiring and developing a strategic portfolio of like-minded companies that believe in the significant potential of the industrial hemp plant. Global Hemp Group’s focused on attracting joint venture partners across all sectors of the industrial hemp industries with the commitment to improve quality of life by researching, developing and distributing sustainable materials, products and services produced from hemp.

The company’s mission is to build a strategic portfolio of hemp-based companies that operate synergistically to consistently deliver a solid ROI to its shareholders. Global Hemp Group has established the concept of Hemp Agro-Industrial Zone (HAIZ) (https://globalhempgroup.com/hempagro/) in order to build cooperative mechanisms across industrial sectors with a focus on different parts of the hemp plant. Under the HAIZ strategy, Global Hemp Group brings together capital, farmers and labor in an effort to build a “soil-to-shelf” portfolio of complimentary companies and joint venture partners in the global hemp industry.

Global Hemp Group has chosen to only work with suppliers of high quality, sustainable raw materials and finished products derived from the hemp plant. Among the leading industries utilizing industrial hemp’s exceptional properties is the automotive sector, building materials market, bio-composites, energy-related markets, super-foods, nutritional supplements, nutraceuticals and the cannabinoid markets. Guided by the principal theme of “global environmental stewardship,” Global Hemp Group focuses on the key concepts of sustainability and social responsibility in all its endeavors.

Global Hemp Group’s joint venture with publicly traded Marijuana Company of America on hemp cultivation trials in 2017, designed to develop commercial hemp production on the Acadian peninsula of New Brunswick, Canada, for the first time in 20 years, was a great success. The partners are preparing for the upcoming changes in Canada’s cannabis legislation that will permit cannabinoid extraction from industrial hemp. Farmers have already been recruited to plant a minimum of 125 acres of industrial hemp for the 2018 growing season, with the goal of increasing the acreage under cultivation to 1,000+ acres by year three of the joint project. Global Hemp Group is preparing an application for a processing license to extract cannabidiol (CBD) and other cannabinoids from the upcoming industrial hemp crop. Discussions are also underway with potential processing partners for the extraction of cannabinoids and straw processing for building materials for the upcoming harvest in October 2018, with a longer term plan to establish permanent processing facilities by October 2019.

Global Hemp Group is led by Charles Larsen as its president, CEO and chairman of the board. Larsen’s more than 30 years of experience working in government, public, private and startup companies as an executive manager includes being the founding president of Medical Marijuana, Inc., the first public company in the Cannabis space. Larsen is also a founder and current director of Marijuana Company of America, Inc., and has been actively involved in the cannabis and hemp industry for nearly a decade. Larsen is joined by Curt Huber, who serves as CFO and director. Huber is an independent corporate and financial consultant with more than 25 years of experience in all facets of public companies among many different sectors including mining, oil and gas, and technology.

Also joining the management team as director is Dr. Paul T. Perrault, an agricultural economist trained in cooperative development and in rural development. Perrault’s experience includes years of consulting on rural development projects introducing new crops in several developing countries and strengthening agricultural research organizations, principally in Africa. Jeff Kilpatrick also serves as a director and is currently a program supervisor of Alachua County Department of Court Services in Gainesville, Florida. Kilpatrick, who spent 21 years in the U.S. Coast Guard, is a member of LEAP – Law Enforcement Against Prohibition – and is president elect for the National Association of Pretrial Services Agencies (NAPSA).

Global Hemp Group’s business philosophy is “A healthier future through sustainable business strategies.“

Global Hemp Group, Inc. (GBHPF), closed the day's trading session at $0.10, even for the day, on 245,995 volume with 35 trades. The average volume for the last 60 days is 158,967 and the stock's 52-week low/high is $0.0115/$0.316.

Recent News

chart

EVIO, Inc. (EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

California is about to undergo a paradigm shift in its cannabis industry that will create a boom for certified testing laboratories. Come the first of July, licensed retail stores can sell only lab-tested cannabis products, meaning there could be a log jam at the laboratory level to keep up with testing demand. That's not a bad problem to have if you are a cannabis-testing lab owner like EVIO Inc. (OTCQB: EVIO), a company on an acquisition bender as part of a goal to end the year with 18 lab locations compared to the 9 it had at the start of the year.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $1.65, up 1.23%, on 103,689 volume with 163 trades. The average volume for the last 60 days is 76,095 and the stock's 52-week low/high is $0.47/$2.70.

Recent News

chart

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Demand for lithium is certain to surge as vehicles become greener, new devices flourish and electricity becomes cleaner. In a testament to the immense opportunity created by the batteries’ versatility, venture capital firms have already pumped a record $1 billion-plus into battery technology this year, more than double all of last year’s total (http://nnw.fm/3TuqE). Surging demand and inadequate market supply have intensified the hunt for new sources of this critical mineral by Lithium Chile, Inc. (TSX-V: LITH) (OTC: LTMCF).

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.6772, off by 2.56%, on 1,500 volume with 1 trade. The average volume for the last 60 days is 1,933 and the stock's 52-week low/high is $0.6599/$0.9021.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB:SING) subsidiary ShieldSaver has signed an agreement with CarFax to provide detailed information directly to CarFax while being able to pull data from the CarFax system to further efficiencies within the ShieldSaver mobile application. ShieldSaver is building relationships with industry leaders and rapidly expanding its presence across the nation through relationships with international airport parking lot management companies, such as WallyPark and LAZ Parking.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.033, off by 0.90%, on 6,317,113 volume with 270 trades. The average volume for the last 60 days is 8,270,831 and the stock's 52-week low/high is $0.0132/$0.415.

Recent News

chart

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P)

The QualityStocks Daily Newsletter would like to spotlight Liberty Leaf Holdings Ltd. (LIBFF).

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is putting together a portfolio of strategically positioned cannabis companies to create a vertically integrated seed-to-sale organization addressing all aspects of the burgeoning cannabis market.

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this dynamic and fast-growing sector. Liberty Leaf provides funding, management, HR resources and marketing expertise to help companies thrive and accelerate growth.

Liberty Leaf’s leading investments to date include:

  • North Road Ventures – An emerging end-to-end distributor of cultivated and manufactured cannabis products to licensed legal retailers. North Road has updated its application for an Access to Cannabis for Medical Purposes Regulations (ACMPR) license to be distribution/sales-focused, making the company unique in the crowded field of other cultivation-based applicants. This forward-thinking initiative will help fulfill the anticipated increase in Canada’s recreational cannabis space once legalization takes effect in mid-2018. The submission includes a boost in product-vault capacity that will result in a five-fold increase in products available for distribution. Cannabidiol (CBD)-oil products are expected to account for 50 percent or more of projected sales.
  • Just Kush Enterprises – Liberty Leaf holds a 60 percent interest in Just Kush, a cultivator of premium, proprietary cannabis strains selected for different levels of CBDs and THCs. Just Kush’s cultivation facility is located near Oliver, British Columbia, and it currently controls a facility which holds a Medical Marihuana Access Regulations (MMAR) license. The company is also a late-stage applicant for an ACMPR license (Access to Cannabis for Medical Purposes Regulations), which will enable Just Kush to produce cannabis for the medicinal and recreational market.

Liberty Leaf is also an active partner with the following companies:

  • ESEV R&D – A privately owned, medical marijuana research and development company based in New York with clinical laboratories located in Israel. ESEV R&D, in collaboration with a leading clinical research organization in Israel, has launched a one-of-a-kind service for North American medical cannabis companies to organize and oversee clinical trials seeking to demonstrate the efficacy of medical cannabis products for specific medical conditions. Liberty Leaf has a three-year collaborative agreement with ESEV. Under that agreement, ESEV is researching the efficacy of CBDs in pets, with the 1st formulation trial targeting canine osteoarthritis, a medical condition that includes: hip dysplasia; elbow dysplasia; and hind-knee, also known as stifle, degenerative joint disease (DJD).
  • Blox Labs Inc. – A boutique technology development company focused on creating best-in-class software solutions driven by emerging trends in blockchain, smart contracts and decentralized application technologies. Liberty Leaf and Blox Labs are developing “cannaBLOX,” a blockchain-based smart contract supply chain management platform for the legalized cannabis industry. The cannaBLOX blockchain software will aim to ease and obliterate logistical bottlenecks, ensure product safety and quality of supply, minimize fraud and potential criminal activity, and assist with taxation and regulatory compliance across various levels of government within the legalized cannabis marketplace. To date, preliminary framework and analysis required for a cannaBLOX Whitepaper has been completed and a development team that specializes in blockchain and decentralized application technologies, including omni-language development in Ethereum and NEO, is now working on the project.

The company’s management team is led by President and Director William Rascan who has 25-plus years in the investment brokerage industry, most recently as a partner, senior investment advisor with Northern Securities. Rascan’s business experience ranges from active international trading clients to raising capital for junior mining companies on the TSX Venture Exchange.

Rascan is joined by CFO Jamie Robinson, a chartered accountant who specializes in accounting, auditing, and financial reporting under both IFRS and ASPE. Prior to joining Liberty Leaf, Robinson worked at Deloitte as a manager focused on publicly listed and private company audits, business review, performance enhancement engagements and restructuring proceedings.

Steven Feldman, who has more than 25 years of experience in the capital markets and was part of the original management team of SouthGobi Resources; and Doug Macdonell, a retired RCMP officer and recognized expert in the field of cannabis and cultivation, serve as company directors. Dr. Robert Jackman, who has worked closely with multiple clients in the medical cannabis and Natural and Non-prescription Health Products (NNHP) industries in North America, was recently appointed as scientific project manager/fulfillment.

Liberty Leaf’s advisory board includes international lawyer, writer and speaker Robert W.E. Laurie; Barinder Rasode, who currently serves as CEO of the National Institute for Cannabis Health & Education (NICHE); and Dr. Mary C. Fitzpatrick, B.S., D.V.M., whose primary focus is on helping companion animals live pain free in their senior years.

Liberty Leaf Holdings Ltd. (LIBFF), closed the day's trading session at $0.2641, off by 10.14%, on 16,736 volume with 21 trades. The average volume for the last 60 days is 52,943 and the stock's 52-week low/high is $0.0091/$0.8074.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.